Is Seeing Believing? A Practitioner’s Perspective on High-Dimensional Statistical Inference in Cancer Genomics Studies
Entropy · 16.09.2024 · 26 (9) · 794
DOI: 10.3390/e26090794 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Entropy, online erschienen am 16.09.2024. Verfasst von Kun Fan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Statistics, Kansas State University, Manhattan, KS 66506, USA. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 189 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Research Award from the Johnson Cancer Research Center at Kansas State University.
Abstract (Originalsprache)
Variable selection methods have been extensively developed for and applied to cancer genomics data to identify important omics features associated with complex disease traits, including cancer outcomes. However, the reliability and reproducibility of the findings are in question if valid inferential procedures are not available to quantify the uncertainty of the findings. In this article, we provide a gentle but systematic review of high-dimensional frequentist and Bayesian inferential tools under sparse models which can yield uncertainty quantification measures, including confidence (or Bayesian credible) intervals, p values and false discovery rates (FDR). Connections in high-dimensional inferences between the two realms have been fully exploited under the “unpenalized loss function + penalty term” formulation for regularization methods and the “likelihood function × shrinkage prior” framework for regularized Bayesian analysis. In particular, we advocate for robust Bayesian variable selection in cancer genomics studies due to its ability to accommodate disease heterogeneity in the form of heavy-tailed errors and structured sparsity while providing valid statistical inference. The numerical results show that robust Bayesian analysis incorporating exact sparsity has yielded not only superior estimation and identification results but also valid Bayesian credible intervals under nominal coverage probabilities compared with alternative methods, especially in the presence of heavy-tailed model errors and outliers.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Statistics, Kansas State University, Manhattan, KS 66506, USA.
- Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Houston, TX 77204, USA.
- Department of Biostatistics and Health Data Sciences, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
ORCID-Profile: Srijana Subedi, Jie Ren
Förderung
- Innovative Research Award from the Johnson Cancer Research Center at Kansas State University
Zitieren
APA
Fan, K., Subedi, S., Yang, G., Lu, X., Ren, J., & Wu, C. (2024). Is Seeing Believing? A Practitioner’s Perspective on High-Dimensional Statistical Inference in Cancer Genomics Studies. Entropy, 26(9), 794. https://doi.org/10.3390/e26090794
Vancouver
Fan K, Subedi S, Yang G, Lu X, Ren J, Wu C. Is Seeing Believing? A Practitioner’s Perspective on High-Dimensional Statistical Inference in Cancer Genomics Studies. Entropy. 2024;26(9):794. doi:10.3390/e26090794
BibTeX
@article{Fan2024,
author = {Fan, Kun and Subedi, Srijana and Yang, Gongshun and Lu, Xi and Ren, Jie and Wu, Cen},
title = {Is Seeing Believing? A Practitioner’s Perspective on High-Dimensional Statistical Inference in Cancer Genomics Studies},
journal = {Entropy},
year = {2024},
volume = {26},
number = {9},
pages = {794},
doi = {10.3390/e26090794}
}
EUVIMED